You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In PNAS this week: Zika virus mutation linked to increased transmission, variants associated with inherited hearing loss, and more.
The technology could be developed into therapies for diseases caused by DNA transversion point mutations, and used to conduct molecular research on such conditions.
UK researchers are to launch a genetic study of chronic fatigue syndrome, the Guardian reports.
In the study, called Coronagenes, the team aims to identify genes that influence the risk of developing COVID-19 and affect disease severity.
A UK consortium aims to sequence COVID-19 patients to uncover genetic variants that may contribute to disease susceptibility or severity.
Illumina will sequence 35,000 whole genomes for the Genetics of Mortality in Critical Care (GenOMICC) study and will provide an in-kind contribution.
A woman's ability to smell differences between people with and without Parkinson's disease could someday lead to a tool to detect the condition early, according to NPR.
In Science this week: phase I study of CRISPR-based engineering of T cells for cancer patients, call for sewage-based global antimicrobial resistance surveillance system, and more.
A new genome-wide association study of income has drawn criticism on Twitter.
Led by investigators at the University of Oslo, the four-year CoMorMent project is slated to commence next month with a total budget of €6 million.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.